Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TNF | P01375 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31462875 | 1.00 | ALDH1A1 (0.49) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL31462885 | 1.00 | ALDH1A1 (0.49) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL31539913 | 1.00 | ALDH1A1 (0.49) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL24944450 | 1.00 | ALDH1A1 (0.49) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL31462848 | 0.98 | CA12 (0.47) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL21203659 | 0.98 | CA12 (0.47) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL31462902 | 0.94 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL23765084 | 0.94 | ALDH1A1 (0.49) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL21203577 | 0.92 | CA12 (0.43) | ALDH1A1HSD17B10CYP3A4HPGDCA12 | |
| SCHEMBL31462896 | 0.91 | ALDH1A1 (0.54) | ALDH1A1HSD17B10CYP3A4HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260047338-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4596528-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024071332-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 保土谷化学工業株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20230129941-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230129941-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260047338-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | HCN1, HCN2, HVCN1 | ALDH1A1 368/4885HSD17B10 683/4885CYP3A4 908/4885 |
| US-20230129941-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SLC1A2, CRY1, NFE2L2 | ALDH1A1 13/4885HSD17B10 2220/4885CYP3A4 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.